Trials / Completed
CompletedNCT02784457
Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome
Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome - a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy of the use of GnRH antagonist in treatment of those who develop early-onset severe ovarian hyperstimulation syndrome and had cancelled embryo transfer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetrorelix |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-12-01
- Completion
- 2016-03-01
- First posted
- 2016-05-27
- Last updated
- 2016-05-27
Source: ClinicalTrials.gov record NCT02784457. Inclusion in this directory is not an endorsement.